[1]
“TP53 Mutation Type and Platinum-Free Interval in Patients with High-Grade Serous Ovarian Cancer”, Вопр. онкол., vol. 70, no. 3, pp. 550–556, Jul. 2024, doi: 10.37469/0507-3758-2024-70-3-550-556.